Cassie Jung serves as Executive at Aquestive Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Cassie Jung has executed 10 insider transactions totaling $784.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Oct 15, 2025 involved exercising options for 25,000 shares valued at $77.5K.
Cassie Jung currently holds 308,346 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cassie Jung has been a net seller of AQST stock. They have purchased $0 and sold $784.6K worth of shares.
Cassie Jung's most recent insider trade was on Oct 15, 2025, when they sold 25,000 shares at $3.10 per share.
Get notified when new Form 4 filings are submitted
| $7.01 |
| Discretionary |
| Sep 4, 2025 | AQST | $17.8K | Option Exercise | 25,000 | $0.71 | Discretionary |
| Sep 4, 2025 | AQST | $310.9K | Sale | 62,180 | $5.00 | Discretionary |
| Sep 4, 2025 | AQST | $78.8K | Option Exercise | 25,000 | $3.15 | Discretionary |
| Mar 10, 2024 | AQST | $5.5K | Payment | 1,132 | $4.88 | Discretionary |
| Mar 9, 2024 | AQST | $40.5K | Payment | 8,300 | $4.88 | Discretionary |
| Mar 7, 2024 | AQST | $0 | Award | 101,250 | $N/A | Discretionary |
| Mar 10, 2023 | AQST | $0 | Payment | 1,365 | $N/A | Discretionary |
| Mar 9, 2023 | AQST | $0 | Award | 110,000 | $N/A | Discretionary |